                         SEQUENCE LISTING

<110>  Massachusetts Institute of Technology et al.
 
<120>  RENAL CLEARABLE NANOCATALYSTS FOR DISEASE MONITORING

<130>  M0656.70443WO00

<140>  Not Yet Assigned
<141>  Concurrently Herewith

<150>  US 62/746,376
<151>  2018-10-16

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  d-amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(7)
<223>  scissile bond

<400>  1

Ser Gly Gly Phe Pro Arg Ser Gly Gly Ser Gly Gly Cys 
1               5                   10              


<210>  2
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  d-amino acid

<220>
<221>  MISC_FEATURE
<222>  (13)..(14)
<223>  scissile bond

<400>  2

Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Phe Pro Arg Ser Gly Gly 
1               5                   10                  15      


Gly Gly Gly Cys 
            20  


<210>  3
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(7)
<223>  scissile bond

<400>  3

Gly Gly Gly Pro Leu Gly Val Arg Gly Lys Gly Gly Cys 
1               5                   10              


<210>  4
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (13)..(14)
<223>  scissile bond

<400>  4

Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Pro Leu Gly Val Arg Gly 
1               5                   10                  15      


Lys Gly Gly Cys 
            20  


<210>  5
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  d-amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(6)
<223>  scissile bond

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  modified by CPQ2-PEG2

<400>  5

Gly Gly Phe Pro Arg Ser Gly Gly Gly Lys Cys 
1               5                   10      


<210>  6
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(6)
<223>  scissile bond

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  modified by CPQ2-PEG2

<400>  6

Gly Gly Pro Leu Gly Val Arg Gly Lys Lys Cys 
1               5                   10      


